Showing results (431-440 of 1,824) with videos related to

Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|July 25, 2026
Lenvatinib enhances the response of biliary tract cancer to anti-HER2 therapyHuishan Sun, Shuofeng Li, Zhe Zhu, et al.
Signal Transduction and Targeted Therapy|April 28, 2021
From purines to purinergic signalling: molecular functions and human diseasesZhao Huang, Na Xie, Peter Illes, et al.
Signal Transduction and Targeted Therapy|July 15, 2026
Targeting the microglial phosphatidylethanolamine synthesis pathway promotes GABARAP-associated phagocytosis and Aβ clearance in Alzheimer's diseaseSeung Jae Hyeon, Seung Chan Kim, Jiyeon Chu, et al.
Signal Transduction and Targeted Therapy|July 17, 2026
A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancerTakuya Tsujino, Shogo Yamazaki, Moritoshi Sakamoto, et al.
Signal Transduction and Targeted Therapy|August 9, 2026
Mechanisms and therapeutic strategies of asthma: from bench to bedsideCong Xie, Ying Wei, Chang Su, et al.
Signal Transduction and Targeted Therapy|August 10, 2026
CAR T cell therapy beyond cancer: current status, challenges and future prospectsSaurabh Upadhyay, Sungwoo Cho, Kirti Upmanyu, et al.
Signal Transduction and Targeted Therapy|August 10, 2026
Hypoxia increases the activity of oncolytic adenoviruses through HIF-2α-stimulated E1A expressionEgon J Jacobus, Véronique N Lafleur, Kerry D Fisher, et al.
Signal Transduction and Targeted Therapy|August 12, 2026
Translational insights and clinical challenges of targeting cancer stem cellsMehreen Ahmed, Amr Al-Haidari, Shruti Agarwal, et al.
Signal Transduction and Targeted Therapy|August 6, 2026
Post-translational modifications in metabolic reprogramming: implications for metabolic therapy and immunotherapy in cancerSi-Jie Chen, Shi-Wei Yue, Yun-Pu Zhang, et al.
Signal Transduction and Targeted Therapy|August 5, 2026
Novel highly selective ROCK2 inhibitor (TDI01) for the treatment of chronic graft-versus-host disease: a multicenter, open-label phase Ib/II studyXiaodong Mo, Xuejun Zhang, Rong Guo, et al.
Pageof 183